InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Domzalski David, Chairman & CEO. Insider active across 1 companies, notably VYNE Therapeutics Inc.. Cumulatively, 15 reports have been recorded. The latest transaction was filed on 31 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
€3,83511,887 shares@ €0.32260.020% mcap2.1% of flow
Common Stock
SEC:0001209191-22-033542:0·
€13,61123,186 shares@ €0.5870.070% mcap7.3% of flow
Common Stock
SEC:0001209191-22-022523:0·
0312,302 shares0
Common Stock
SEC:0001209191-22-020064:0·
€6,2036,887 shares@ €0.90070.032% mcap7.4% of flow
Common Stock
SEC:0001209191-22-000852·
€6,2036,887 shares@ €0.90070.032% mcap3.3% of flow
Common Stock
SEC:0001209191-22-000852:0·
€3,6474,705 shares@ €0.77520.019% mcap4.3% of flow
Common Stock
SEC:0001209191-21-067646·
€3,6474,705 shares@ €0.77520.019% mcap2.0% of flow
Common Stock
SEC:0001209191-21-067646:0·
€15,72713,096 shares@ €1.20090.081% mcap18.7% of flow
Common Stock
SEC:0001209191-21-058514·
€15,72713,096 shares@ €1.20090.081% mcap8.5% of flow
Common Stock
SEC:0001209191-21-058514:0·
0320,312 shares0
Common Stock
SEC:0001209191-21-054833·
0320,312 shares0
Common Stock
SEC:0001209191-21-054833:0·
€55,82918,859 shares@ €2.96030.29% mcap66.5% of flow
Common Stock
SEC:0001209191-21-044975·
€55,82918,859 shares@ €2.96030.29% mcap30.1% of flow
Common Stock
SEC:0001209191-21-044975:0·
€2,591941 shares@ €2.75360.013% mcap3.1% of flow
Common Stock
SEC:0001209191-21-037189·
€2,591941 shares@ €2.75360.013% mcap1.4% of flow
Common Stock
SEC:0001209191-21-037189:0·
15 of 15 declarations
About Domzalski David
David Domzalski is an executive at VYNE Therapeutics Inc.
